Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status (2021)
Attributed to:
Structural Studies on Viruses, Viral Proteins and Cell Interactions
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.03.21.21254061
Publication URI: http://dx.doi.org/10.1101/2021.03.21.21254061
Type: Preprint